NYUCD RECEIVES $3.5 MILLION GIFT TO SUPPORT ORAL CANCER RESEARCH, TREATMENT, AND TRAINING INITIATIVES OF DR. BRIAN SCHMIDT
September 24, 2010
The NYU College of Dentistry has received an anonymous gift in the amount of $3.5 million to support the oral cancer research, treatment, and training initiatives of Dr. Brian L. Schmidt, the newly appointed Director of the Bluestone Center for Clinical. These initiatives center on early detection, pain control, and improved reconstruction in the treatment of oral cancer patients. They include:
Dr. Schmidt and his colleague Dr. John Dolan, winner of the National Inventors Hall of Fame Foundation Collegiate Inventors Competition Graduate Award, will research and develop a prototype for jaw replacement, fabricated in titanium, to be delivered at the time of oral cancer resection to replace the patient’s missing jaws and teeth.
- Developing an innovative oral cancer pain and neuroscience research program
- Identifying genetic and proteomic markers at the time of diagnosis to predict the progression of an oral cancer and subsequently, to tailor treatment based upon that prediction
- Investigating saliva as a cancer predictor, which might make it possible to follow a patient with a precancerous lesion simply by giving a saliva sample that would be analyzed in the laboratory for certain predictive markers
- Establishing a yearlong postdoctoral research fellowship for investigators who wish to develop expertise in the area of cancer pain by focusing on relevant questions that must be addressed in the laboratory
- Improving oral cancer survivors’ quality of life by expanding a program dedicated to facial construction following surgical resection
“We are thrilled by the generosity of this unrestricted gift, which will support Dr. Schmidt’s goal of enhancing the quality of life for oral cancer”.